Breast Neoplasms: all 12,820 studies
Page 14 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast CancerRecruitingNCT06757621Phase 3
- A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast CancerNot yet recruitingNCT06757335Phase 1/2
- BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast CancerRecruitingNCT06756932Phase 1
- Breast Cancer Rehabilitation Needs and Service UptakeNot yet recruitingNCT06753357
- Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)Not yet recruitingNCT06751407Not applicable
- Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast CancerNot yet recruitingNCT06750848Phase 2
- Efficacy of the Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Breast Cancer Surger.(SPSIP) Block is a Novel Regional Anesthesia Technique Targeting the Dorsal Rami and Intercostal Nerves (T2-T6), Providing Sensory Blockade to Both the Posterior and Lateral AspectNot yet recruitingNCT06750835Not applicable
- DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHYRecruitingNCT06749210Phase 2
- E-Mindfulness Approaches for Living After Breast CancerRecruitingNCT06748222Phase 3
- Hemopatch Implication After Axillary Dissection for Breast CancerNot yet recruitingNCT06744998Not applicable
- NearWave Optical Molecular MonitoringRecruitingNCT06744465Not applicable
- Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate DepressionRecruitingNCT06741540Not applicable
- Preoperative Radiation Therapy and Immediate Breast ReconstructionRecruitingNCT06739655Not applicable
- A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic CancerRecruitingNCT06738966Phase 1
- Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast CancerRecruitingNCT06738459
- Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer PatientsRecruitingNCT06737926Not applicable
- A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast CancerNot yet recruitingNCT06733233Phase 2
- HER2-PET Imaging in HER2-low Breast CancersRecruitingNCT06732336Phase 1/2
- Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer SurvivorsRecruitingNCT06731894Phase 2
- JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBCNot yet recruitingNCT06731153Phase 2
- Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation TherapyRecruitingNCT06729814
- Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer SurvivorsRecruitingNCT06729684Not applicable
- Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer PatientsNot yet recruitingNCT06729099
- PARTial BREast RECONstruction With Chest Wall Perforator FlapRecruitingNCT06728527
- Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast CancerNot yet recruitingNCT06728150
- Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast CancerRecruitingNCT06727773Phase 2
- OvS Breast: Ovarian Suppression in Breast Cancer InterventionsRecruitingNCT06727487Not applicable
- Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast CancerRecruitingNCT06727227
- Increasing Oral Medication Adherence for Metastatic Breast Cancer PatientsRecruitingNCT06726889
- Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid TumorsRecruitingNCT06726148Phase 1/2
- GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast CancerRecruitingNCT06725940
- Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor SurgeryRecruitingNCT06725082Phase 1
- Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)RecruitingNCT06724835Phase 1
- Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast CancerRecruitingNCT06723899Not applicable
- A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain MetastesisNot yet recruitingNCT06723132
- Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast CancerRecruitingNCT06722612
- A Randomized Controlled Trial to Increase Breast Cancer Screening UptakeNot yet recruitingNCT06722469Not applicable
- Genitourinary Syndrome of Menopause in Breast CancerRecruitingNCT06721936Not applicable
- A Study of Language Interpretation Solutions for People With Breast CancerRecruitingNCT06721065Not applicable
- Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan StudyRecruitingNCT06719206Not applicable
- Study of SHR-A1811 Combined with Pyrotinib and Bevacizumab in Advanced Breast Cancer with Brain MetastasisRecruitingNCT06718933Phase 1/2
- Pyrotinib in HER2-positive Early Breast CancerNot yet recruitingNCT06718335Not applicable
- The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast CancerRecruitingNCT06718010
- AI Model for Classifying Breast Cancer From Histopathology ImagesRecruitingNCT06717984
- Target-specific immunoPET Imaging of Breast CancerRecruitingNCT06715826Phase 1/2
- Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular ImagingRecruitingNCT06715020Not applicable
- Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic StatusRecruitingNCT06713161
- Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)Not yet recruitingNCT06711939
- Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based ChemotherapyRecruitingNCT06711185Phase 3
- Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABCNot yet recruitingNCT06711094Not applicable
- Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target TherapyRecruitingNCT06711068
- Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast CancerRecruitingNCT06711055
- A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy MethodsNot yet recruitingNCT06708221Not applicable
- Role of MRI in Breast Cancer SubtypesNot yet recruitingNCT06707584
- To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast CancerNot yet recruitingNCT06706726Not applicable
- Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.RecruitingNCT06705127Phase 2
- No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant ChemotherapyRecruitingNCT06704945Phase 3
- Study on Recurrent Breast Cancer and Repeated Radiation TherapyRecruitingNCT06704659Not applicable
- IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4RecruitingNCT06703567Not applicable
- Clinical Exploratory Study on Predicting Drug Sensitivity for Breast Cancer Treatment Using Simulated Organoid Models.RecruitingNCT06702800
- Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCRecruitingNCT06700382
- The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast CancerRecruitingNCT06698679
- Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: a Clinical StudyRecruitingNCT06697938Not applicable
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Axillary LNs Evalution in Breast Cancer by Multimodal UsNot yet recruitingNCT06695052
- Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast CancerRecruitingNCT06694519Not applicable
- Safe and Explainable AIRecruitingNCT06694181
- Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant TherapyRecruitingNCT06693037
- Adjuvant Therapy With Neratinib in HER2 Positive Early Breast CancerRecruitingNCT06693024
- Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and ChemotherapyNot yet recruitingNCT06691594Phase 2
- Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer PatientsRecruitingNCT06690840Phase 2
- The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast CancerRecruitingNCT06690645
- Effect of Planned Education on Health Beliefs and Fatalism in Women at High Risk of Breast CancerEnrolling by invitationNCT06690320Not applicable
- Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)RecruitingNCT06686394Phase 1/2
- Feasibility Study of CBCT for IGRT in Cancer PatientsRecruitingNCT06681233Not applicable
- Breast Cancer Evolution During Neoadjuvant Systemic TherapyRecruitingNCT06681064
- Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd TherapyEnrolling by invitationNCT06680596Phase 2
- A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer PatientsRecruitingNCT06679036Phase 1/2
- A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerRecruitingNCT06678269Phase 1
- Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast CancerNot yet recruitingNCT06678230Phase 2
- Arsenous Acid for Refractory Triple-Negative Breast CancerRecruitingNCT06678048Phase 2
- Preoperative Partial Breast Irradiation in Early-Stage Breast CancerRecruitingNCT06677944Phase 2
- A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.RecruitingNCT06677879Phase 2
- Outcomes of a Novel Technique Minimal Scar MastectomyRecruitingNCT06676761
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer PatientsRecruitingNCT06672497
- A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast CancerRecruitingNCT06672302
- Exercise in Triple- Negative Breast CancerRecruitingNCT06672120Not applicable
- A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I TrialEnrolling by invitationNCT06671691Phase 1
- Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving SurgeryNot yet recruitingNCT06671249Not applicable
- Study of SYN818 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT06666270Phase 1
- The Ohio State University (OSU) SCREEN Community ProgramRecruitingNCT06666192Not applicable
- Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast CancerRecruitingNCT06665178Phase 2
- Ultrahypofractionated Whole Breast Radiation Following ChemotherapyNot yet recruitingNCT06664892Not applicable
- ARX788 in HER2-positive Metastatic Breast Cancer PatientsRecruitingNCT06663748Phase 2
- Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AIRecruitingNCT06663228
- Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast CancerRecruitingNCT06660628Not applicable
- Planning Grant for TOPS for Breast Cancer SurvivorsRecruitingNCT06658912Not applicable
- Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast CancerRecruitingNCT06658080
- Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)RecruitingNCT06656624Phase 2